Newer drugs keep multiple sclerosis patients out of wheelchairs – expert

Abstract

There are fewer multiple sclerosis patients in wheelchairs than ever before in South Africa, mainly due to the advent of interferon drugs over the last decade with better second line drugs over the past three years, says Prof. Girish Modi, Head of Neurology at the University of the Witwatersrand.